Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells

Clinical Cancer Research (2004) - Comments
pubmed: 15073106 issn: 1078-0432 doi: 10.1158/1078-0432.ccr-1183-3 issn: 1557-3265

Mark S Duxbury, Hiromichi Ito, Michael J Zinner, Stanley W Ashley, Edward E Whang